Pascale Ehouarn
Chief Tech/Sci/R&D Officer at DBV TECHNOLOGIES
Network origin in Pascale Ehouarn first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 49 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pascale Ehouarn via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer | |
Imperial College London | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Investor | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | President Director of Finance/CFO | |
NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | General Counsel Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree | |
BETTER COLLECTIVE A/S | Director of Finance/CFO Chairman | ||
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member | |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IDORSIA LTD | Director/Board Member Director/Board Member | ||
Ipsen Pharma SA
Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
EUROAPI | Biotechnology | Director/Board Member Chairman | |
Institut National Agronomique Paris-Grignon | College/University | Graduate Degree Graduate Degree | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
ESCP Europe Campus Paris | College/University | Undergraduate Degree Masters Business Admin | |
Bpifrance Participations SA | Financial Conglomerates | Chief Investment Officer | |
SEQUANS COMMUNICATIONS S.A. | Director/Board Member | ||
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
American Academy of Pediatrics
American Academy of Pediatrics Medical/Nursing ServicesHealth Services American Academy of Pediatrics operates as a professional association of pediatricians to the optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults. The company was founded on June 23, 1930 and is headquartered in Elk Grove Village, IL. | Medical/Nursing Services | Corporate Officer/Principal |
Statistics
International
France | 16 |
United States | 7 |
Denmark | 4 |
United Kingdom | 4 |
Netherlands | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 8 |
Finance | 3 |
Transportation | 2 |
Government | 2 |
Operational
Director/Board Member | 258 |
Corporate Officer/Principal | 97 |
Independent Dir/Board Member | 69 |
Chairman | 65 |
Director of Finance/CFO | 36 |
Most connected contacts
Insiders | |
---|---|
Peter Hutt | 69 |
Mette Agger | 30 |
Michel de Rosen | 28 |
Torbjørn Bjerke | 27 |
Chahra Khaoua Epouse Louafi | 26 |
Flemming Heise Pedersen | 24 |
Didier Hoch | 24 |
Rafaèle Elisabeth Tordjman | 23 |
Timothy Morris | 21 |
Viviane Monges | 21 |
Maïlys Ferrère | 21 |
Jens Bager | 18 |
Daniel Tassé | 16 |
Julie O'Neill | 16 |
Claire Giraut | 16 |
- Stock Market
- Insiders
- Pascale Ehouarn
- Company connections